非荷爾蒙避孕藥市場規模、佔有率、成長分析（按性別、產品類型、分銷管道和地區） - 產業預測，2025-2032

2023年非荷爾蒙避孕藥的全球市場規模為306.7億美元，從2024年的326.6億美元成長到2032年的540.6億美元，預計在預測期內（2025年-2032 年）將持續成長。率為6.5%。

非荷爾蒙避孕藥包括多種避免荷爾蒙成分的避孕方法，主要透過抑制卵子受精和著床。主要類別包括屏障方法、生育意識技術和子宮內避孕器 (IUD)。避孕套和隔膜等屏障方法為精子提供了物理屏障，具有高可用性和最小的副作用，但有效性需要持續使用，並且不能預防性傳播感染。生育意識方法追蹤月經週期以避免排卵期間性交，但可能因週期不規則而失敗。子宮內避孕器（含銅且不含荷爾蒙）可提供有效、長期的保護，且每日使用量極少。然而，插入可能會感到不舒服，並且會增加骨盆腔發炎的風險，隨著女性健康意識的增強，消費者對避孕選擇做出明智的選擇被認為很重要。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析
• 監管分析

非荷爾蒙避孕藥市場規模：性別

• 市場概況
• 男性
• 女士

按產品類型分類的非荷爾蒙避孕藥市場規模

• 市場概況
• 保險套
• 隔膜
• 子宮頸帽
• 殺精劑
• 避孕海綿

非荷爾蒙避孕藥市場規模：依分銷管道分類

• 市場概況
• 零售藥房
• 醫院藥房
• 網路藥房
• 其他

非荷爾蒙避孕藥市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2022-2024）

主要企業簡介

• The Female Health Company
• Reckitt Benckiser Group plc（Durex）
• Church & Dwight Co., Inc.（Trojan）
• Ansell Ltd.
• Okamoto Industries Inc.
• Fuji Latex Co., Ltd.
• Mayer Laboratories, Inc.
• Cooper Surgical Inc.
• Medicines360
• The Population Council, Inc.
• V-Care Pharma Pvt. Ltd.
• Veru Inc.
• Afaxys, Inc.
• Bayer AG
• Cupid Limited

結論和建議

Global Non-Hormonal Contraception Market size was valued at USD 30.67 billion in 2023 and is poised to grow from USD 32.66 billion in 2024 to USD 54.06 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

Non-hormonal contraception encompasses various birth control methods that avoid hormonal components, primarily by inhibiting fertilization or implantation of an egg. Key categories include barrier methods, fertility awareness techniques, and intrauterine devices (IUDs). Barrier methods, like condoms and diaphragms, provide a physical barrier against sperm, boasting high availability and minimal side effects, though efficacy demands consistent use and does not guard against STIs. Fertility awareness methods track menstrual cycles to avoid intercourse during ovulation but may falter with irregular cycles. IUDs, both copper-based and hormone-free, offer effective, long-lasting prevention requiring minimal daily action. However, they can cause discomfort during insertion and increase PID risk, placing importance on informed consumer choice in contraception options as awareness of women's health grows.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Hormonal Contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segmental Analysis

Global Non-Hormonal Contraception Market is segmented by gender, product type, distribution channel and region. Based on gender, the market is segmented into male and female. Based on product type, the market is segmented into condoms, diaphragms, cervical caps, spermicides and contraceptive sponges. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is significantly driven by the rising awareness surrounding contraceptive methods. As family planning becomes more prioritized, individuals are increasingly looking for effective and safe alternatives to hormonal contraceptives. The availability of educational resources and counseling services has empowered consumers with knowledge about various contraceptive options, fostering a shift towards non-hormonal solutions. This heightened awareness has translated into a growing demand for non-hormonal contraceptives, as consumers seek products that align with their safety and effectiveness preferences. In response to this trend, manufacturers are actively innovating and developing new non-hormonal contraceptive options to cater to the evolving needs of the market.

Restraints in the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market encounters significant challenges due to restricted availability and low awareness in developing nations. Many of these countries lack the necessary infrastructure and resources to ensure access to non-hormonal contraceptive options. Moreover, cultural and religious beliefs often impede the acceptance and distribution of contraceptive methods, leading to increased rates of unintended pregnancies and sexually transmitted infections. This situation not only impacts individual health outcomes but also stifles the overall growth potential of the non-hormonal contraception market, as these barriers prevent effective education and access, ultimately limiting market expansion opportunities.

Market Trends of the Global Non-Hormonal Contraception Market

A prominent trend in the global non-hormonal contraception market is the surging demand for natural and organic contraceptive solutions. As awareness regarding the potential side effects of hormonal contraceptives grows, consumers are increasingly gravitating towards alternatives devoid of synthetic hormones or chemicals. Products such as condoms and natural family planning methods are experiencing heightened popularity, being recognized for their safety and eco-friendliness. This inclination towards natural options is further fueled by a broader societal shift towards sustainability and environmental consciousness, prompting manufacturers to innovate and market eco-friendly contraceptive alternatives that resonate with health-conscious and environmentally-aware consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Non-Hormonal Contraception Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Male
• Female

Global Non-Hormonal Contraception Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Condoms
• Diaphragms
• Cervical Caps
• Spermicides
• Contraceptive Sponges

Global Non-Hormonal Contraception Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others

Global Non-Hormonal Contraception Market Size & CAGR (2025-2032)

• North America (Gender, Product Type, Distribution Channel)
  • US
  • Canada
• Europe (Gender, Product Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Gender, Product Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Gender, Product Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Gender, Product Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (Durex)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (Trojan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cooper Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Population Council, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations